Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 5;103(9):761-770.
doi: 10.2106/JBJS.20.01853.

Assessing the Value to the Patient of New Technologies in Anatomic Total Shoulder Arthroplasty

Corey J Schiffman  1 , Pooja Prabhakar  1 , Jason E Hsu  1 , Michele L Shaffer  2 , Ljubomir Miljacic  3 , Frederick A Matsen 3rd  1
Affiliations
Review

Assessing the Value to the Patient of New Technologies in Anatomic Total Shoulder Arthroplasty

Corey J Schiffman et al. J Bone Joint Surg Am. .

Abstract

Background: Publications regarding anatomic total shoulder arthroplasty (TSA) have consistently reported that they provide significant improvement for patients with glenohumeral arthritis. New TSA technologies that have been introduced with the goal of further improving these outcomes include preoperative computed tomography (CT) scans, 3-dimensional preoperative planning, patient-specific instrumentation, stemless and short-stemmed humeral components, as well as metal-backed, hybrid, and augmented glenoid components. The benefit of these new technologies in terms of patient-reported outcomes is unknown.

Methods: We reviewed 114 articles presenting preoperative and postoperative values for commonly used patient-reported metrics. The results were analyzed to determine whether patient outcomes have improved over the 20 years during which new technologies became available.

Results: The analysis did not identify evidence that the results of TSA were statistically or clinically improved over the 2 decades of study or that any of the individual technologies were associated with significant improvement in patient outcomes.

Conclusions: Additional research is required to document the clinical value of these new technologies to patients with glenohumeral arthritis.

Level of evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors indicated that no external funding was received for any aspect of this work. On the Disclosure of Potential Conflicts of Interest forms, which are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author had a relevant financial relationship in the biomedical arena outside the submitted work and “yes” to indicate that the author had other relationships or activities that could be perceived to influence, or have the potential to influence, what was written in this work (http://links.lww.com/JBJS/G350).

Comment in

References

    1. Hughes M, Neer CS 2nd. Glenohumeral joint replacement and postoperative rehabilitation. Phys Ther. 1975 Aug;55(8):850-8.
    1. Neer CS 2nd. Unconstrained shoulder arthroplasty. Instr Course Lect. 1985;34:278-86.
    1. Hsu JE, Hackett DJ Jr, Vo KV, Matsen FA 3rd. What can be learned from an analysis of 215 glenoid component failures? J Shoulder Elbow Surg. 2018 Mar;27(3):478-86. Epub 2018 Jan 5.
    1. Matsen FA 3rd, Clinton J, Lynch J, Bertelsen A, Richardson ML. Glenoid component failure in total shoulder arthroplasty. J Bone Joint Surg Am. 2008 Apr;90(4):885-96.
    1. Papadonikolakis A, Neradilek MB, Matsen FA 3rd. Failure of the glenoid component in anatomic total shoulder arthroplasty: a systematic review of the English-language literature between 2006 and 2012. J Bone Joint Surg Am. 2013 Dec 18;95(24):2205-12.